Breaking News

Catalent Launches Applied Drug Delivery Institute

By Gil Roth | October 17, 2012

Will involve industry, academy, customers and regulators to advance delivery innovation

Catalent Pharma Solutions has launched the Catalent Applied Drug Delivery Institute at the 2012 American Association of Pharmaceutical Scientists (AAPS) Annual Meeting and Exposition. According to a company statement, the Institute aspires to promote innovation, knowledge-sharing, and collaboration between industry leaders, academic experts, customers and regulators to enhance understanding of available, emerging, and future drug delivery technologies and improve patient care.

“The mission of the Catalent Applied Drug Delivery Institute is to bring better treatments to market by advancing the development and adoption of applied drug delivery technologies,” stated Kurt Nielsen, Ph.D., Catalent's senior vice president of R&D. “By harnessing the knowledge of some of the world’s leading experts in drug development, delivery and formulation, the Institute will cultivate leadership and excellence in drug development through education, training, and innovation.”

As part of its mission, the Institute will serve as a link between industry and academia by providing guidance, counsel, and resources on major issues pertaining to drug development, delivery, and formulation. The Institute will develop programs that "facilitate mutually beneficial collaborations, increase communication, and shed light on regulatory issues affecting drug developers and researchers," accord to Catalent. It also will pursue a multi-tiered approach of seed funding, strategic counsel, and educational programs to advance the adoption of emerging technologies.

“Today is an exciting day for Catalent Pharma Solutions and the Catalent Applied Drug Delivery Institute, as well as for everyone working in the areas of drug delivery and development,” said Rao Tatapudy, vice president of Scientific Affairs at Catalent. “In launching the Institute at AAPS, we hope to start an informative and productive dialog between industry and academic experts that will spur innovation at the benchtop and in the marketplace. We look forward to a continuous series of successful collaborations as the Institute’s activities unfold.”
 
The company announced a series of Institute-led initiatives and publications designed to "enhance understanding of drug delivery and inspire the next generation of science leaders." These initiatives, which will target both industry and academic audiences, will include:
 

  • Applied drug delivery events and training programs for industry
  • Innovation and research collaborations with universities and technology companies
  • Catalent Applied Drug Delivery Institute scientific journal
  • Science Leaders of Tomorrow university partnership program
  • Student drug delivery guide
  • Annual Drug Delivery Landscape Technology Survey
  • Scientific communications
 
More information about the Catalent Applied Drug Delivery Institute is available at www.drugdeliveryinstitute.com.

blog comments powered by Disqus
  • 16th Annual $alary $urvey

    16th Annual $alary $urvey

    Tim Wright, Editor||June 3, 2015
    Welcome to Contract Pharma’s Sixteenth Annual Salary Survey! This year’s results are derived from more than 500 respondents f

  • Newsmakers: PCI

    Newsmakers: PCI

    Tim Wright, Editor||June 2, 2015
    PCI execs talk about the recent opening of the company’s new North American clinical facility, as well as other trends in the market

  • How Sterilization of Primary Packaging Influences the Results of E&L Studies

    How Sterilization of Primary Packaging Influences the Results of E&L Studies

    Thorsten Sogding, Daniel Canton, Daniel Haines, Uwe Rothhaar, SCHOTT Pharma Services ||June 2, 2015
    As the demands that are being placed on the quality and stability of medications continue to increase, the interactions that take place between the primary packaging container and filled drug product are becoming increasingly important